Інформація призначена тільки для фахівців сфери охорони здоров'я, осіб,
які мають вищу або середню спеціальну медичну освіту.


Підтвердіть, що Ви є фахівцем у сфері охорони здоров'я.

"Gastroenterology" Том 52, №2, 2018

Back to issue

The use of elastography in patients with chronic liver diseases

Authors: Журавлева Л.В., Огнева Е.В.
Харьковский национальный медицинский университет, г. Харьков, Украина

Categories: Gastroenterology

Sections: Specialist manual

print version


Summary

У статті розглянуті переваги й недоліки неінвазивного методу діагностики фіброзу печінки — еластографії. Описано види даного методу дослідження, області застосування. Вказані найбільш ефективні види еластографії для різних хронічних захворювань печінки (хронічні гепатити В і С, неалкогольна жирова хвороба печінки, аутоімунні захворювання гепатобіліарної системи та алкогольна хвороба печінки). Проаналізовані дані нових рандомізованих контрольованих досліджень.

В статье рассмотрены преимущества и недостатки неинвазивного метода диагностики фиброза печени — эластографии. Описаны виды данного метода исследования, области применения. Указаны наиболее эффективные виды эластографии для различных хронических заболеваний печени (хронические гепатиты В и С, неалкогольная жировая болезнь печени, аутоиммунные заболевания гепатобилиарной системы и алкогольная болезнь печени). Проанализированы данные новых рандомизированных контролируемых исследований.

The article considers the advantages and disadvantages of the non-invasive method for diagnosing liver fibrosis — elastography. The types of this research method, applications were described. The most effective types of elastography for various chronic liver diseases were indicated (chronic hepatitis B and C, non-alcoholic fatty liver disease, autoimmune diseases of the hepatobiliary system and alcoholic liver disease). The latest research results were analyzed.


Keywords

хронічні захворювання печінки; фіброз печінки; еластографія

хронические заболевания печени; фиброз печени; эластография

сhronic liver diseases; liver fibrosis; elastography


For the full article you need to subscribe to the magazine.


Bibliography

1. Brunt E.M. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions / E.M. Brunt, C.G. Janney, A.M. Di Bisceglie et al. // Am. J. Gastroenterol. — 1999. — Vol. 94(9). — P. 2467-2474.
2. Calès P. Liver fibrosis diagnosis by blood test and elastography in chronic hepatitis C: agreement or combination? / P. Calès, J. Boursier, J. Lebigot et al. // Aliment. Pharmacol. Ther. — 2017. — Vol. 45(7). — P. 991-1003. 
3. Calvaruso V. Regression of fibrosis after HBV antiviral the–rapy. Is cirrhosis reversible? / V. Calvaruso, A.Craxì // Liver Int. — 2014. — Vol. 34(Suppl. 1). — P. 85-90. 
4. Cassinotto C. Liver stiffness in nonalcoholic fatty liver disease: A comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy / C. Cassinotto, J. Boursier, V. de Lédinghen et al. // Hepatology. — 2016. — Vol. 63(6). — P. 1817-1827. 
5. Castéra L. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C / L. Castéra, J. Vergniol, J. Foucher et al. // Gastroenterology. — 2005. — Vol. 128(2). — P. 343-350. 
6. Chen J. Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography / J. Chen, J.A.M. Talwalkar et al. // Radiology. — 2011. — Vol. 259(3). — P. 749-756. 
7. Corpechot C. Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis / C. Corpechot, F. Carrat, A. Poujol-Robert et al. // Hepatology. — 2012. — Vol. 56(1). — P. 198-208. 
8. Cui J. Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease: a prospective study / J. Cui, B. Ang, W. Haufe et al. // Aliment. Pharmacol. Ther. — 2015. — Vol. 41(12). — P. 1271-1280. 
9. EASL-ALEH clinical practice guidelines: non-invasive tests for evaluation of liver disease severity and prognosis // J. Hepatol. — 2015. — Vol. 63(1). — P. 237-264. 
10. EASL-EASD-EASO clinical practice guidelines for the ma–nagement of non-alcoholic fatty liver disease // J. Hepatol. — 2016. — Vol. 64(6). — P. 1388-1402. 
11. Eaton J.E. Performance of magnetic resonance elastography in primary sclerosing cholangitis / J.E. Eaton, B. Dzyubak, S.K. Venkates et al. // J. Gastroenterol. Hepatol. — 2016. — Vol. 31(6). — P. 1184-1190. 
12. Ehlken H. Validation of transient elastography and comparison with spleen length measurement for staging of fibrosis and clinical prognosis in primary sclerosing cholangitis / H. Ehlken, R. Wroblew–ski, C. Corpechot et al. // PLoS One. — 2016. — Vol. 11(10). — P. e0164224. 
13. Ekstedt M. Fibrosis stage is the strongest predictor for di–sease-specific mortality in NAFLD after up to 33 years of follow-up / M. Ekstedt, H. Hagström, P. Nasr et al. // Hepatology. — 2015. — Vol. 61(5). — P. 1547-1554. 
14. European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu. EASL recommendations on treatment of hepatitis C 2016 // J. Hepatol. — 2017. — Vol. 66(1). — P. 153-194
15. Ferraioli G. Ultrasound point shear wave elastography assessment of liver and spleen stiffness: effect of training on repeatability of measurements / G. Ferraioli, C. Tinelli, R. Lissandrin et al. // Eur. Radiol. — 2014. — Vol. 24(6). — P. 1283-1289. 
16. Fierbinteanu Braticevici C. Value of acoustic radiation force impulse imaging elastography for non-invasive evaluation of patients with nonalcoholic fatty liver disease / Braticevici C. Fierbinteanu, I. Sporea, E. Panaitescu, L. Tribus // Ultrasound Med. Biol. — 2013. — Vol. 39(11). — P. 1942-1950. 
17. Friedrich-Rust M. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis / M. Friedrich-Rust, M.F. Ong, S. Martens et al. // Gastroenterology. — 2008. — Vol. 134(4). — P. 960-974. 
18. Gonzalez H.C. Role of liver biopsy in the era of direct-acting antivirals / H.C. Gonzalez, S.M. Jafri, S.C. Gordon // Curr. Gastroenterol. Rep. — 2013. — Vol. 15(2). — P. 307. 
19. Hu X. Acoustic radiation force impulse (ARFI) elastography for non-invasive evaluation of hepatic fibrosis in chronic hepatitis B and C patients: a systematic review and meta-analysis / X. Hu, L. Qiu, D. Liu et al. // Med. Ultrason. — 2017. — Vol. 19(1). — P. 23-31. 
20. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group // Hepatology. — 1994. — Vol. 20. — P. 15-20. 
21. Jajamovich G.H. Quantitative liver MRI combining phase contrast imaging, elastography, and DWI: assessment of reproduci–bility and postprandial effect at 3.0 / G.H. Jajamovich, H. Dyvorne, C. Donnerhack, B.T. Taouli // PLoS One. — 2014. — Vol. 9(5). — P. e97355. 
22. Jiang T. Diagnostic accuracy of 2D-shear wave elastography for liver fibrosis severity: a meta-analysis / T. Jiang, G. Tian, Q. Zhao et al. // PLoS One. — 2016. — Vol. 11(6). — P. e0157219. 
23. Kennedy P. Quantitative Elastography Methods in Liver Disease: Current Evidence and Future Directions / P. Kennedy, W. Mathilde, C. Laurent et al. // Radiology. — 2018. — Vol. 286 (3). 
24. Kiani A. Acoustic radiation force impulse imaging for assessing liver fibrosis in alcoholic liver disease / A. Kiani, V. Brun, F. Lainé et al. // World J. Gastroenterol. — 2016. — Vol. 22(20). — P. 4926-4935. 
25. Kwok R. Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease — the role of transient elastography and plasma cytokeratin-18 fragments / R. Kwok, Y.K. Tse, G.L. Wong et al. // Aliment Pharmacol Ther. — 2014. — Vol. 39(3). — P. 254-269. 
26. Myers R.P. Feasibility and diagnostic performance of the Fibro–Scan XL probe for liver stiffness measurement in overweight and obese patients / R.P. Myers, G. Pomier-Layrargues, R. Kirsch et al. // Hepatology. — 2012. — Vol. 55(1). — P. 199-208. 
27. Nobili V. Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis / V. Nobili, F. Vizzutti, U. Arena et al. // Hepatology. — 2008. — Vol. 48(2). — P. 442-448. 
28. Ophir J. Elastography: a quantitative method for imaging the elasticity of biological tissues / J. Ophir, İ. Céspedes, H. Ponnekanti et  al. // Ultrason Imaging. — 1991. — 13(2). — P. 111-134. 
29. Puigvehí M. Impact of anthropometric features on the applicability and accuracy of FibroScan® (M and XL) in overweight/obese patients / M. Puigvehí, T. Broquetas, S. Coll et al. // J. Gastroenterol. Hepatol. — 2017. — Vol. 32(10). — P. 1746-1753. 
30. Regev A. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection / A. Regev, M. Berho, LJ. Jeffers et al. // Am. J. Gastroenterol. — 2002. — Vol. 97(10). — P. 2614-2618.
31. Serai S.D. Repeatability of MR elastography of liver: a meta-analysis / S.D. Serai, N.A. Obuchowski, S.K. Venkatesh et al. // Radiology. — 2017. — Vol. 285(1). — P. 92-100. 
32. Singh S. Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data / S. Singh, S.K. Venkatesh, Z. Wang et al. // Clin. Gastroenterol. Hepatolş. — 2015. — Vol. 13(3). — P. 440-451.e6. 
33. Şirli R. Comparison between the M and XL probes for liver fibrosis assessment by transient elastography / R. Şirli, I. Sporea, A. Deleanu et al. // Med. Ultrason. — 2014. — Vol. 16(2). — P. 119-122. 
34. Suwanthawornkul T. Efficacy of second generation direct-acting antiviral agents for treatment naïve hepatitis C genotype 1: a systematic review and network meta-analysis / T. Suwanthawornkul, T. Anothaisintawee, A. Sobhonslidsuk et al. // PLoS One. — 2015. — Vol. 10(12). — P. 0145953. 
35. Terrault N.A. AASLD guidelines for treatment of chronic hepatitis B / N.A. Terrault, N.H. Bzowej, K.M. Chang et al. // Hepatology. — 2016. — Vol. 63(1). — P. 261-283. 
36. Thiele M. Transient and 2-dimensional shear-wave elasto–graphy provide comparable assessment of alcoholic liver fibrosis and cirrhosi / M. Thiele, S. Detlefsen, L. Sevelsted Møller et al. // Gastroenterology. — 2016. — Vol. 150(1). — P. 123-133. 
37. Verlinden W. Liver fibrosis evaluation using real-time shear wave elastography in hepatitis C-monoinfected and human immunodeficiency virus/hepatitis C-coinfected patients / W. Verlinden, S. Bourgeois, P. Gigase et al. // J. Ultrasound Med. — 2016. — Vol. 35(6). — P. 1299-1308. 
38. Wagner M. Technical failure of MR elastography examinations of the liver: experience from a large single-center study / M. Wagner, I. Corcuera-Solano, G. Lo et al. // Radiology. — 2017. — Vol. 284(2). — P. 401-412. 
39. Wang J. Magnetic resonance elastography is accurate in detecting advanced fibrosis in autoimmune hepatitis / J. Wang, N. Malik, M. Yin et al. // World J. Gastroenterol. — 2017. — Vol. 23(5). — P. 859-868. 
40. Woo H. Comparison of the reliability of acoustic radiation force impulse imaging and supersonic shear imaging in measurement of liver stiffness / H. Woo, J.Y. Lee, J.H. Yoon et al. // Radiology. — 2015. — Vol. 277(3). — P. 881-886. 
41. Xu Q. Evaluation of transient elastography in assessing li–ver fibrosis in patients with autoimmune hepatitis / Q. Xu, L. Sheng, H. Bao et al. // J. Gastroenterol. Hepatol. — 2017. — Vol. 32(3). — P. 639-644. 
42. Yada N. Influence of liver inflammation on liver stiffness measurement in patients with autoimmune hepatitis evaluation by combinational elastography / N. Yada, T. Sakurai, T. Minami et al. // Oncology. — 2017. — Vol. 92(Suppl. 1). — P. 10-15. 
43. Yoneda M. Nonalcoholic fatty liver disease: US-based acoustic radiation force impulse elastography / M. Yoneda, K. Suzuki, S. Kato et al. // Radiology. — 2010. — Vol. 256(2). — P. 640-647. 
44. Yoon J.H. Hepatic fibrosis: prospective comparison of MR elastography and US shear-wave elastography for evaluation / J.H. Yoon, J.M. Lee, İ. Joo et al. // Radiology. — 2014. — Vol. 273(3). — P. 772-782. 
45. Zarski J.P. Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: the ANRS HCEP-23 study / J.P. Zarski, N. Sturm, J. Guechot et al. // Hepatol. — 2012. — Vol. 56(1). — P. 55-62. 

Similar articles

Sonological methods for diagnosing liver steatosis and fibrosis in children
Authors: Yu.M. Stepanov, N.Yu. Zavhorodnia, O.Yu. Lukianenko, V.B. Yahmur, I.S. Konenko, O.P. Petishko
State Institution “Institute of Gastroenterology of the National Academy of Medical Sciences of Ukraine”, Dnipro, Ukraine

"Gastroenterology" Том 52, №3, 2018
Date: 2018.09.24
Categories: Gastroenterology
Sections: Clinical researches
Современные Методы определения фиброза печени
Authors: Диденко В.И. - ГУ «Институт гастроэнтерологии НАМН Украины», г. Днепропетровск
"Gastroenterology" 2 (48) 2013
Date: 2013.06.19
Categories: Gastroenterology, Investigation methods
Sections: Clinical researches
Жорсткість печінки за даними зсувнохвильової еластографії у хворих на цукровий діабет типу 2 з неалкогольною жировою хворобою печінки залежно від активності процесу НАЖХП
Authors: Динник О.Б. - Інститут фізіології ім. О.О. Богомольця НАН України; Михальчишин Г.П., Кобиляк Н.М., Боднар П.М. - Національний медичний університет ім. О.О. Богомольця, м. Київ
"Gastroenterology" 3 (53) 2014
Date: 2014.09.18
Categories: Gastroenterology
Sections: Clinical researches
Сomparative Study of Progepar Efficacy in Patients with Non-Alcoholic Steatohepatitis
Authors: Perederii V.G., Syzenko G.K. - National Medical University named after O.O. Bohomolets, Kyiv, Ukraine
"Gastroenterology" 4 (58) 2015
Date: 2016.02.16
Categories: Gastroenterology
Sections: Clinical researches

Back to issue